CRSP: CRISPR Therapeutics Inc Net earnings per share for the last 12 months

Symbol and logo of brand CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG (CRSP) has cemented its status as a pioneer by receiving the first approval for a genome-editing drug. The 12-month rolling specific income metric visualizes the current trend, where the value of -4.74 serves as the current indicator. Prospects rely on monopoly pricing power in DNA therapy, although high R&D costs make future cash flows difficult to predict.

CRISPR (CRSP) - Earnings per share for the last four quarters from 07/04/2022 to 11/18/2026

Analytical breakdowns and data insights for company CRISPR (CRSP)

- current quotes and average value forecast:
General company analysis:crisprtx.com (CRSP)
Manufactured products of CRISPR Therapeutics Corp

The market values CRISPR Therapeutics AG (CRSP) as a high-tech asset, where the dynamics of the rolling net income per share reflect the actual efficiency of profit distribution among shareholders, accounting for the current volume of issuance. This metric allows investors to assess the success of commercializing genetic innovations, confirming management's ability to transform scientific breakthroughs into concrete financial returns per share.

Competitors of CRISPR Therapeutics AG (CRSP)

TEM: Net earnings per share for the last 12 months|QGEN (Qiagen Group) - Earnings per share for the last 12 months|Ionis (IONS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Repligen Inc. (RGEN)|RNA (Avidity Biosciences) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months genedx.com WGS|Net earnings per share for the last 12 months RARE (Ultragenyx Corp)|BEAM (Beam Therapeutics) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) SRPT (Sarepta Therapeutics Inc)|Net earnings per share for the last four quarters Twist Bio (TWST)|TXG: Net earnings per share for the last 12 months|Earnings per share for the trailing year NTLA (Intellia Therapeutics)|Stoke Therapeutics (STOK) - Earnings per share for the last twelve months|BioLife Corp (BLFS) - Net earnings per share (EPS TTM)|WVE (wavelifesciences.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Maze Therapeutics Inc|Net earnings per share (EPS TTM) SION|PRME - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) TSHA (Taysha Corp)|Earnings per share for the trailing year QURE|MeiraGTx Holdings - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year REGENXBIO Corp (RGNX)|solidbio.com (SLDB) - Earnings per share for the last twelve months|Earnings per share for the last 12 months OCGN|PACB (PacBio Corp) - Net earnings per share (EPS TTM)|BNTC: Earnings per share for the trailing year|Earnings per share for the last twelve months Design Corp (DSGN)|Net earnings per share for the last 12 months Rocket Pharmaceuticals Inc RCKT|FDMT: Net earnings per one share for the last twelve months|LXEO: Earnings per share for the last 12 months|Korro Bio, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Editas Medicine|Silence Therapeutics (SLN) - Earnings per share for the last twelve months|PRQR (ProQR Therapeutics N.V.) - Earnings per share for the last twelve months|CDXS (Codexis Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months sangamo.com (SGMO)|Net earnings per share (EPS TTM) NAUT|Net earnings per share (EPS TTM) Metagenomi (MGX)|Earnings per share for the last twelve months Precision BioSciences DTIL|Net earnings per share (EPS TTM) Generation Bio Corp GBIO|Boundless Bio, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Exicure Inc.|Imunon, Inc. (IMNN) - Earnings per share for the last twelve months|RXi Pharmaceuticals (PHIO) - Net earnings per share (EPS TTM)|MBIO (Mustang Bio Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months RNAZ (TransCode Therapeutics)|Net earnings per share (EPS TTM) BNGO|APDN: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) BLUE (bluebird bio Inc.)|Net earnings per share for the last four quarters ImmunoPrecise Antibodies (IPA)|OMGA: Net earnings per share for the last 12 months|OMIC (Singular Genomics Systems Inc) - Earnings per share for the last 12 months|Regulus Therapeutics (RGLS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months syros.com (SYRS)|TBIO (Telesis Bio Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months TRACON Pharmaceuticals Inc. (TCON)|Net earnings per share for the last 12 months UBX (Unity Biotechnology, Inc.)